A detailed history of Renaissance Investment Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Renaissance Investment Group LLC holds 2,270 shares of AMGN stock, worth $600,392. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,270
Previous 2,270 -0.0%
Holding current value
$600,392
Previous $709,000 3.1%
% of portfolio
0.16%
Previous 0.16%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$262.75 - $319.31 $52,550 - $63,862
-200 Reduced 8.1%
2,270 $709,000
Q1 2024

Apr 29, 2024

SELL
$268.87 - $324.56 $21,778 - $26,289
-81 Reduced 3.18%
2,470 $702,000
Q4 2023

Jan 09, 2024

BUY
$255.7 - $288.46 $255,700 - $288,460
1,000 Added 64.47%
2,551 $734,000
Q3 2023

Oct 10, 2023

SELL
$218.65 - $271.46 $8,090 - $10,044
-37 Reduced 2.33%
1,551 $416,000
Q2 2023

Jul 06, 2023

SELL
$214.27 - $253.37 $39,425 - $46,620
-184 Reduced 10.38%
1,588 $352,000
Q1 2023

Apr 05, 2023

SELL
$225.79 - $275.2 $16,031 - $19,539
-71 Reduced 3.85%
1,772 $428,000
Q3 2022

Oct 25, 2022

SELL
$224.46 - $253.15 $152,408 - $171,888
-679 Reduced 26.92%
1,843 $482,000
Q2 2022

Jul 12, 2022

SELL
$230.71 - $256.74 $12,689 - $14,120
-55 Reduced 2.13%
2,522 $614,000
Q1 2022

May 03, 2022

SELL
$219.27 - $242.57 $25,216 - $27,895
-115 Reduced 4.27%
2,577 $595,000
Q4 2021

Feb 04, 2022

SELL
$198.88 - $227.6 $2.61 Million - $2.99 Million
-13,146 Reduced 83.0%
2,692 $606,000
Q3 2021

Nov 02, 2021

SELL
$212.27 - $248.7 $532,585 - $623,988
-2,509 Reduced 13.68%
15,838 $3.37 Million
Q2 2021

Jul 08, 2021

SELL
$233.58 - $259.14 $91,563 - $101,582
-392 Reduced 2.09%
18,347 $4.47 Million
Q1 2021

Apr 01, 2021

BUY
$221.91 - $258.6 $81,662 - $95,164
368 Added 2.0%
18,739 $4.66 Million
Q4 2020

Jan 26, 2021

BUY
$216.38 - $257.67 $268,743 - $320,026
1,242 Added 7.25%
18,371 $4.22 Million
Q3 2020

Oct 22, 2020

BUY
$234.65 - $260.95 $191,005 - $212,413
814 Added 4.99%
17,129 $4.35 Million
Q2 2020

Jul 07, 2020

BUY
$197.81 - $242.74 $2.72 Million - $3.34 Million
13,768 Added 540.56%
16,315 $3.85 Million
Q1 2020

May 08, 2020

BUY
$182.24 - $241.7 $12,939 - $17,160
71 Added 2.87%
2,547 $516,000
Q4 2019

Jan 22, 2020

BUY
$189.21 - $243.2 $40,869 - $52,531
216 Added 9.56%
2,476 $596,000
Q3 2019

Oct 17, 2019

BUY
$174.11 - $208.62 $129,189 - $154,796
742 Added 48.88%
2,260 $438,000
Q2 2019

Jul 17, 2019

SELL
$166.7 - $195.41 $25,838 - $30,288
-155 Reduced 9.26%
1,518 $280,000
Q1 2019

Apr 19, 2019

BUY
$180.87 - $203.88 $302,595 - $341,091
1,673 New
1,673 $318,000
Q3 2018

Oct 30, 2018

SELL
$185.29 - $208.89 $299,428 - $337,566
-1,616 Closed
0 $0
Q4 2017

Jan 03, 2018

BUY
$168.79 - $188.59 $843 - $942
5 Added 0.31%
1,616 $281,000
Q3 2017

Oct 12, 2017

BUY
$167.29 - $191.0 $269,504 - $307,701
1,611
1,611 $301,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Renaissance Investment Group LLC Portfolio

Follow Renaissance Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Investment Group LLC with notifications on news.